High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.

Creative Commons License

Celebioglu B., Gurkan O., Erdogan S., Savas I., Kose K., Kurtman C., ...Daha Fazla

Japanese journal of clinical oncology, cilt.32, sa.11, ss.443-8, 2002 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 11
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1093/jjco/hyf102
  • Dergi Adı: Japanese journal of clinical oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.443-8
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Background: Intraluminal brachytherapy has become an established treatment for major airway occlusion by relapsed or persistent inoperable endobronchial tumors. The aim of this study was to compare the palliation improvement pre- and post-radiotherapy.